PMC:7105881 / 26079-26294
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 769 | 34-42 | Species | denotes | SARS-CoV | Tax:694009 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T114 | 123-130 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T112 | 34-42 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T113 | 85-89 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T120 | 123-130 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T156 | 0-215 | Sentence | denotes | Numerous subunit vaccines against SARS-CoV have been developed since the outbreak of SARS, the majority of which use the S protein and/or its antigenic fragments, in particular, RBD, as the vaccine target (Table 1). |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T506 | 34-42 | SP_10 | denotes | SARS-CoV |
| T507 | 85-89 | SP_10 | denotes | SARS |
| T508 | 121-130 | PG_1 | denotes | S protein |
| T509 | 142-151 | CHEBI:59132;CHEBI:59132 | denotes | antigenic |
| T33727 | 34-42 | SP_10 | denotes | SARS-CoV |
| T35137 | 85-89 | SP_10 | denotes | SARS |
| T98807 | 121-130 | PG_1 | denotes | S protein |
| T16034 | 142-151 | CHEBI:59132;CHEBI:59132 | denotes | antigenic |